• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Res . Epidemiological characteristics and the entire evolution of coronavirus disease 2019 in Wuhan, China

tetano

Editor, Senior Moderator
Respir Res


. 2020 Oct 8;21(1):257.
doi: 10.1186/s12931-020-01525-7.
Epidemiological characteristics and the entire evolution of coronavirus disease 2019 in Wuhan, China


Dongming Wang[SUP] 1 2 [/SUP], Jing Cai[SUP] 3 [/SUP], Tingming Shi[SUP] 4 [/SUP], Yang Xiao[SUP] 1 2 [/SUP], Xiaobing Feng[SUP] 1 2 [/SUP], Meng Yang[SUP] 1 2 [/SUP], Wenzhen Li[SUP] 5 [/SUP], Wei Liu[SUP] 1 2 [/SUP], Linling Yu[SUP] 1 2 [/SUP], Zi Ye[SUP] 1 2 [/SUP], Tao Xu[SUP] 1 2 [/SUP], Jixuan Ma[SUP] 1 2 [/SUP], Mingyan Li[SUP] 6 [/SUP], Weihong Chen[SUP] 7 8 [/SUP]



Affiliations

Abstract

Background: Coronavirus Disease 2019 (COVID-19) spread rapidly around the world. We aimed to describe the epidemiological characteristics and the entire evolution of COVID-19 in Wuhan, and to evaluate the effect of non-pharmaceutical intervention by the government.
Methods: The information of COVID-19 cases until Mar 18, 2020 in Wuhan were collected from the national infectious disease surveillance system in Hubei province.
Results: A total of 49,973 confirmed cases were reported until Mar 18, 2020 in Wuhan. Among whom, 2496 cases died and the overall mortality was 5.0%. Most confirmed cases (25,619, 51.3%) occurred during Jan 23 to Feb 4, with a spike on Feb 1 (new cases, 3374). The number of daily new cases started to decrease steadily on Feb 19 (new cases, 301) and decreased greatly on Mar 1 (new cases, 57). However, the mortality and the proportion of severe and critical cases has been decreasing over time, with the lowest of 2.0 and 10.1% during Feb 16 to Mar 18, 2020, respectively. The percentage of severe and critical cases among all cases was 19.6%, and the percentage of critical and dead cases aged over 60 was 70.1 and 82.0%, respectively.
Conclusion: The number of new cases has dropped significantly after the government taking the isolation of four types of personnel and the community containment for 14 days. Our results indicate that the mortality and proportion of severe and critical cases gradually decreased over time, and critical and dead cases are more incline to be older individuals.

Keywords: Coronavirus disease 2019 (COVID-19); Epidemiological characteristics; Evolution; Non-pharmaceutical interventions.
 
Back
Top Bottom